20207 ⎘
Medicinal preparations containing organic active ingredients Sulfur, selenium, or tellurium compounds, e.g. thiols
Sub-classes:MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)
#2ACETYL-COA CARBOXYLASE MODULATORS
#3NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEIN
#4METHODS FOR TREATING FIBROSIS USING PKM2 ACTIVATORS
#5COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
#6METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES
#7NOVEL MOLECULES
#8ANTI-VWF THERAPEUTIC FOR PREVENTING ARTERIAL THROMBI
#9USE OF SRE-PTPRZ1 INHIBITOR IN PREPARATION OF DRUG FOR TREATING SQUAMOUS CELL CARCINOMA
#10ELECTROLYTES FOR ADDRESSING LOW IRON
#11HYDROXYAMIDE DERIVATIVE AND USE THEREOF
#12WATER-SOLUBLE HETEROCYCLYL POLYMETHINE CHROMOPHORES
#13Use of Thiol Compounds to Treat Neurological Disease
#14Compounds and compositions for neurodegenerative diseases
#15DRUG CONJUGATES FOR BONE MARROW PROTECTION
#16COMPOSITIONS FOR DELIVERING NITRIC OXIDE AND FLUORIDE AND METHODS FOR MAKING AND USING THE SAME
#17TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#18FLAVANOID CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS
#19DIFLUOROCARBENE RADIOSYNTHESIS
#20Tethering Cysteine Residues Using Cyclic Disulfides
#21Methods related to opioid therapeutics
#22PRODRUGS OF TAPINAROF
#23COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS
#24NOVEL REDOX-BASED THERAPEUTIC APPROACH FOR TREATMENT OF CANCER
#25Precision Medicine Approach to Treating Parkinson's Disease with a Monoamine Oxidase Inhibitor, an Antioxidant, or Both
#26COMPOUNDS USEFUL FOR TREATING LIVER DISEASES
#27COMPOSITIONS AND METHODS FOR TREATMENT OF MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION AND OTHER MITOCHONDRIAL DISORDERS
#28ANTI-VIRAL AGENT
#29Method for Side Effect Reduction in the Use of Statins Via Physiologically Synthesized Glutathione
#30DIAGNOSTIC METHODS FOR T CELL THERAPY
#31Methods and compositions for modifying mucous membranes
#32FOLATE RECEPTOR-TARGETED CONJUGATES, COMPOSITIONS, AND DELIVERY TO THE CENTRAL NERVOUS SYSTEM
#33USE OF CELL TURNOVER FACTORS FOR INCREASING TISSUE REGENERATION
#34Stabilization of epinephrine formulations
#35SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA
#36PH-RESPONSIVE LIPIDOID NANOPARTICLES FOR INTRACELLULAR MRNA DELIVERY
#37TREATMENTS FOR CANCERS HAVING KRAS MUTATIONS
#38MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME
#39THIOL-CONTAINING COMPOUNDS FOR USE IN TREATING CORONAVIRUS
#40Bismuth-thiol compositions and methods of use
#41BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS
#42Additive for Detoxification
#43Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
#44MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES
#45Use of thiol compounds to treat neurological disease
#46TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#47Method of treatment of topical dermatologic acne using a cream composition and method of manufacture
#48NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEINS
#49COMPOSITIONS AND METHODS TO TREAT GASTROINTESTINAL DISEASES AND DISORDERS
#50COMPOSITIONS FOR THE TREATMENT OF HYPERKERATOSIS DISORDERS
#51COMPOSITIONS FOR DISRUPTING BIOFILM FORMATION AND FOR TREATING BIOFILM-RELATED DISORDERS
#52Prooxidative chain-transfer agents for use in the treatment of malignant tumour or infectious diseases
#53SKIN COMPOSITION
#54COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
#55SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX
#56Bicyclic heteroaryl derivatives and preparation and uses thereof
#57C60 GLUTATHIONE DOPA AND METHODS
#58Administration of antipsychotics
#59METHODS OF IMPROVING REPRODUCTIVE AND RESPIRATORY HEALTH
#60THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#61TREATMENT OF MAJOR DEPRESSIVE DISORDER AND SUICIDAL IDEATIONS THROUGH STIMULATION OF HIPPOCAMPAL NEUROGENESIS UTILIZING PLANT-BASED APPROACHES
#62PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF
#63Tethering cysteine residues using cyclic disulfides
#64Methods of treatment comprising Selenoprotein P fragment-containing compounds
#65BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#66Main agent uniformly dispersed microsphere and a sustained release formulation comprising the same
#67Methods related to opioid therapeutics
#68AP39 IMPACT ON MITOCHONDRIA, METABOLISM, GENE TRANSCRIPTION REGULATION, CARDIOTOXICITY PROTECTION AND CANCER TREATMENT
#69DECREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#70Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#71ACETYL-COA CARBOXYLASE MODULATORS
#72Methods and compositions for modifying mucous membranes
#73Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway
#74COMPOSITION AND METHOD OF AN IRON SUPPLEMENT
#75STABILIZATION OF EPINEPHRINE FORMULATIONS
#76Bicyclic heteroaryl derivatives and preparation and uses thereof
#77Use of Thiol Compounds to Treat Neurological Disease
#78COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A CALCINEURIN INHIBITOR
#79TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#80Tethering cysteine residues using cyclic disulfides
#81PROTECTIVE METALLOTHIONEIN ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC DISEASES
#82THERAPEUTIC METHODS RELATING TO HSP90 INHIBITORS
#83Stable, highly pure L-cysteine compositions for injection and methods of use
#84TOPICAL DERMATOLOGIC ACNE TREATMENT CREAM COMPOSITION AND METHOD OF MANUFACTURE
#85Bicyclic heteroaryl derivatives and preparation and uses thereof
#86THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#87Compositions for the Treatment of Hyperkeratosis Disorders
#88METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
#89Pharmaceutical formulations of nitrite and uses thereof
#90Methods for treating diseases
#91PHARMACEUTICAL COMPOSITION CONTAINING CELECOXIB
#92Treatment methods and processes for an infected nail
#93Bismuth-thiol compositions and methods of use
#94FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY
#95Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
#96Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
#97Combinations and methods comprising a capsid assembly inhibitor
#98Poly(ketals) and related compositions and methods
#99STABILIZATION OF EPINEPHRINE FORMULATIONS
#100Combination inhibiting MEIS proteins
#101Hydrogen sulphide compounds
#102METHOD OF MAKING THROMBORESISTANT/BACTERICIDAL S-NITROSO-N-ACETYLPENICILLAMINE (SNAP)-IMPREGNATED NITRIC OXIDE RELEASE POLYMERS WITH ENHANCED STABILITY
#103Pharmaceutical composition containing a cis-diamine platinum thione complex
#104Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#105Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
#106Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea
#107Production of water-soluble hydrolyzed clinoptilolite fragments
#108Method for treating a prolifitive disorder with a cis-diamine platinum complex
#109Method of Preparing Solid Dispersions of Active Pharmaceutical Ingredients
#110Pharmaceutical composition containing celecoxib
#111Acetyl-CoA carboxylase modulators
#112Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
#113Anticancer activity of cis-diamine platinum(II) complexes of thiones
#114Methods for inhibiting conversion of choline to trimethylamine (TMA)
#115THERAPEUTIC METHODS RELATING TO HSP90 INHIBITORS
#116MATERIALS AND METHODS FOR TREATING HYPOXIC CONDITIONS
#117Pharmaceutical composition for improving or preventing progression of chronic kidney disease
#118Pharmaceutical formulations of nitrite and uses thereof
#119NITRIC OXIDE GENERATING FORMULATIONS AND KITS
#120Personal cleansing compositions and methods of stabilizing the microbiome
#121Compositions and methods for inhibiting Wnt signaling
#122Agent for preventing and/or treating Alzheimer's disease
#123THERAPEUTIC AGENT FOR BILIARY TRACT CANCER
#124Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient
#125SHIP1 MODULATORS AND METHODS RELATED THERETO
#126Diagnostic methods for T cell therapy
#127Selenium-based therapies
#128Compounds as L-cystine crystallization inhibitors and uses thereof
#129BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#130Methods and compositions for modifying mucous membranes
#131Tethering cysteine residues using cyclic disulfides
#132Tethering cysteine residues using cyclic disulfides
#133Process for preparation of cysteamine bitartrate
#134Pharmaceutical composition containing Celecoxib
#135NUTRITIONAL SUPPLEMENT COMPOSITION
#136Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles
#137SHIP1 modulators and methods related thereto
#138METHODS AND MATERIALS FOR PROMOTING BONE FORMATION
#139METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS
#140COMPOSITIONS AND COMBINATIONS FOR THE TREATMENT OF ANGIOGENESIS DISEASES AND DISORDERS
#141Pyrazolothiazole compound and medicine comprising same
#142Spiro-lactam NMDA receptor modulators and uses thereof
#143Pharmaceutical composition comprising polypeptide
#144Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
#145Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma
#146Beta lactamase inhibitors
#147THIOTRIAZOLE COMPOUND AND ITS USE IN PARASITIC PROTOZOAL INFECTIONS
#148Method for the preparation of N-acetyl cysteine amide
#149ANESTHETIC AND ROOT CANAL PREPARATION LUBRICANT COMPOSITION
#150Combinations and methods comprising a capsid assembly inhibitor
#151Methods for enhancing hematopoietic stem/progenitor cell engraftment
#152Spiro-lactam NMDA receptor modulators and uses thereof
#153METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR
#154A METHOD FOR SIDE EFFECT REDUCTION IN THE USE OF STATINS VIA PHYSIOLOGICALLY SYNTHESIZED GLUTATHIONE
#155Fatty acid cysteamine conjugates and their use as activators of autophagy
#156Pyrazolothiazole compound and medicine comprising same
#157SODIUM TETRADECYL SULFATE FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE
#158Use of silver(I) complexes as anticancer agents
#159SHIP1 modulators and methods related thereto
#160Method for preparation of N-acetyl cysteine amide
#161Nitric Oxide Donors
#162Compounds and methods for inhibiting production of trimethylamine
#163Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
#164Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#165Method for assessing and treating or preventing impaired plasma polar lipid levels
#166Cannabinoid receptor treatments
#167Methods of treating tumoral diseases, or bacterial or viral infections
#168Antimicrobial compositions comprising glyceryl nitrates
#169Anti-cancer compositions and methods
#170Honey-based dressing for the treatment of wounds and burns
#171METHOD AND SYSTEM FOR SECLUDING A BODY VESSEL
#172TOPICAL LIPOLYSIS COMPOSITIONS AND METHODS
#173NANO CO-ENCAPSULATION FOR THE PREVENTION AND TREATMENT OF VARIOUS DISORDERS
#174Tethering cysteine residues using cyclic disulfides
#175METHOD FOR PRE-SCREENING AND CORRELATION OF UNDERLYING SCARB1 GENE VARIATION TO ATHEROSCLEROSIS IN WOMEN AND THERAPEUTIC USE OF PROGESTATIONAL AND OTHER MEDICATIONS IN TREATMENT
#176INJECTABLE ALBUMIN BASED VASCULAR OCCLUDER
#177Cellulose ethers esterified with dicarboxylic acid
#178Trace elements
#179Dithiol compounds, derivatives, and uses therefor
#180Mitochondrially-targeted electrophilic compounds and methods of use for the treatment of cancer
#181Methods and compositions for modifying mucous membranes
#182Acetyl CoA carboxylase modulators
#183Hydrogen sulphide compounds
#184Compositions and methods for treating or preventing metabolic syndrome disorders
#185Methods of improving reproductive and respiratory health
#186Treatment of mastocytosis with masitinib
#187Resveratrol selenide preparation for treating cancer
#188Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer
#189Sodium tetradecyl sulfate formulations for treatment of adipose tissue
#190TREATMENT OF MASTOCYTOSIS WITH MASITINIB
#191Polyalkoxylated alcohols as excipients for pharmaceutical compositions
#192Complex targeting hepatitis B virus
#193Oral care composition containing ionic liquids
#194METHODS AND COMPOSITIONS RELATING TO TREATMENT OF CANCER
#195Tethering cysteine residues using cyclic disulfides
#196Methods for enhancing hematopoietic stem/progenitor cell engraftment
#197Antimicrobial compositions and related methods
#198Anti-cancer compositions and methods
#199Methods of treating ocular diseases using derivatives of lipoic acid
#200Transdermal venous access locking solutions
#201AZAADAMANTANE DERIVATIVES AND METHODS OF USE
#202ARIPIPRAZOLE-ORGANIC ACID COCRYSTAL, PREPARATION OR COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR
#203Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof
#204Compositions and methods for increasing neurotrophic peptides
#205S-nitrosothiol-generating skin dressings
#206Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
#207Methods of treating ocular diseases using derivatives of lipoic acid
#208Apparatus for the controlled release of topical nitric oxide
#209Dithiol compounds and treatment of presbyopia using said compounds
#210Anti-cancer compositions and methods
#211BIS-AROMATIC ANTICANCER AGENTS
#212Water-soluble anti-inflammatory cream with natural ingredients base
#213METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES
#214Compounds and compositions thereof
#215METHODS AND COMPOSITIONS TO ELIMINATE CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANT CELLS IN STROMAL MICROENVIRONMENT FOR CANCER THERAPY
#216Derivatives of tetracaine
#217Method for pre-screening and correlation of underlying SCARB1 gene variation to infertility in women and therapeutic use of progestational and other medications in treatment
#218Therapeutic compounds for blocking DNA synthesis of POX viruses
#219MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES
#220Aliphatic amino acid biosynthesis inhibitors and a method of synthesizing the same
#221Anti-cancer compositions and methods
#222Controlled chemical release of hydrogen sulfide
#223Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
#224Anti-cancer compositions and methods
#225Anti-cancer compositions and methods
#226PHARMACEUTICAL COMPOSITION COMPRISING LEVOCARNITINE AND DOBESILATE
#227Selenium-based biocidal formulations and methods of use thereof
#228Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
#229Anti-Viral Compounds
#230PHARMACEUTICAL PREPARATIONS COMPRISING A COS RELEASING COMPOUND
#231Therapeutic compounds for blocking DNA synthesis of pox viruses
#232SELENALZOLE DERIVATIVE HAVING LIGAND WHICH ACTIVATES PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR), PREPARING METHOD THEREOF AND USAGE OF THE CHEMICAL COMPOUNDS
#233Compounds as L-cystine crystallization inhibitors and uses thereof
#234Organosulfur prodrugs for the prevention and treatment of infectious diseases
#235ANTI-MICROBIAL ORTHODONTIC COMPOSITIONS AND APPLIANCES AND METHODS OF PRODUCTION AND USE THEREOF
#236Lysine Specific Demethylase-1 inhibitors and their use
#237METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR HIF MODULATING COMPOUNDS
#238SULFATE SALTS AS TRANSIT TIME ENHANCER
#239ANTIOXIDANTS FOR USE IN THERAPY
#240Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
#241ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
#242Method for treating a keratoconjunctival disorder
#243Antimicrobial Compositions
#244Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#245Small-molecule modulators of Trp-p8 activity
#246METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS
#247METHODS AND COMPOSITIONS FOR ENHANCING SURVIVABILITY OF CELLS, TISSUES, ORGANS AND ORGANISMS
#248TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING FEMALE'S REPRODUCTIVE SYSTEM FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY
#249NUTRITIONAL OR THERAPEUTIC COMPOSITIONS TO INCREASE BODILY GLUTATHIONE LEVELS
#250Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis
#251COMPOSITIONS AND METHODS FOR INHIBITING NF-KB MEDIATED TUMORIGENICITY AND ADHESION-DEPENDENT SURVIVAL OF CANCER CELLS
#252Methods for enhancing hematopoietic stem/progenitor cell engraftment
#253TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING MALE'S FERTILITY FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY
#254Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
#255Method of treating viral infections by administration of ethyl mercury or thiol derivative thereof
#256Parenteral selenomethionine for production of selenium-rich foods
#257METHOD FOR PRODUCING TABLET COMPRISING NATURAL ALLICIN
#258Method to induce fatty liver in animal
#259Aniline analogs as glycogen synthase activators
#260Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds
#261Treatment of Inflammatory Conditions and Diseases with Metal-Thiols
#262Methods for modulating metabolism
#263USE OF ALKYL SULFATES OR SULFONATES AGAINST PROPIONIBACTERIUM ACNES
#264Bis-aromatic anticancer agents
#265Tablet comprising natural allicin and method for producing the same
#266METHODS FOR REDUCING TOXICITIES ASSOCIATED WITH MEDICAL PROCEDURES EMPLOYING RADIOGRAPHIC CONTRAST AGENTS
#267METHODS AND COMPOSITIONS FOR ALTERING CELL FUNCTION
#268Compounds and method for coating surfaces in a hemocompatible manner
#269Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#270METHOD FOR TREATING AMYLOIDOSIS
#271Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
#272Methods of treating ocular diseases using derivatives of lipoic acid
#273Compositions and Methods for Reducing the Toxicity of Certain Toxins
#274METHODS AND COMPOSITIONS FOR INHIBITING INTEGRINS USING TELLURIUM-CONTAINING COMPOUNDS
#275Compositions for the treatment of hoof diseases
#276PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE
#277Preparation for restenosis prevention
#278Preparation for restenosis prevention
#279METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION
#280Nitric oxide donors
#281Compositions comprising A C2-C14 carboxylic acid and a surfactant for treating hoof diseases
#282Antimicrobial Compositions And Related Methods
#283Process for the treatment of bacterial infections using 2-phenyl-1,2-benzisoselenazol-3(2H)-one 1-oxide
#284Method of using biothionol and biothionol-like compounds as anti-angiogenic agents
#285ULTRASONIC NANOTHERAPY OF SOLID TUMORS WITH BLOCK COPOLYMERS STABILIZED PERFLUOROCARBON NANODROPLETS
#286SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF
#287SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF
#288ANTI-ANGIOGENIC AGENTS AND METHODS OF USE
#289THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR DEMYELINATING DISEASE COMPRISING AMINO ALCOHOL DERIVATIVE AS ACTIVE INGREDIENT
#290Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis
#291Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
#292Use of an antibacterial compound which is derived from alliaceae, as a natural additive in animal feed
#293Therapeutic compounds for blocking DNA synthesis of pox viruses
#294Anti-microbial orthodontic compositions and appliances and methods of production and use thereof
#295Antimicrobial compositions
#296Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
#297AGENT FOR TREATING EYE DISEASES
#298Compositions with enhanced elasticizing activity
#299Methods for Screening Interleukin-6 (IL-6) Signal Transduction Inhibitors
#300No-modified hemoglobins and uses therefor